Rallybio
Stock Forecast, Prediction & Price Target
Rallybio Financial Estimates
Rallybio Revenue Estimates
Rallybio EBITDA Estimates
Rallybio Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $185.4M Low: $185.4M High: $185.4M avg. 0% | Avg: $618.5M Low: $618.5M High: $618.5M avg. 233.60% |
Net Income
% change YoY
| $-47.01M N/A | $-66.48M -41.43% | $-74.56M -12.14% | Avg: $-47.50M Low: $-84.13M High: $-22.54M avg. 36.29% | Avg: $-44.08M Low: $-80.49M High: $-17.39M avg. 7.20% | Avg: $44.08M Low: $44.08M High: $44.08M avg. 200.01% | Avg: $334.90M Low: $334.90M High: $334.90M avg. 659.63% |
EBITDA
% change YoY
| $-45.49M N/A | $-65.57M -44.13% | $-72.37M -10.36% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.46 N/A | -$2.09 -43.15% | -$1.84 11.96% | Avg: -$1.43 Low: -$2.08 High: -$0.56 avg. 22.42% | Avg: -$1.21 Low: -$1.99 High: -$0.43 avg. 15.23% | Avg: $1.09 Low: $1.09 High: $1.09 avg. 190.08% | Avg: $8.28 Low: $8.28 High: $8.28 avg. 659.63% |
Operating Expenses
% change YoY
| $45.64M N/A | $67.88M 48.71% | $78.93M 16.27% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Rallybio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 225.78% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -84.13M, average is -47.50M and high is -22.54M.
What is Rallybio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 58.40% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Rallybio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 221.84% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.08, average is -$1.43 and high is $-0.55.